Inventor · disambiguated record
Hideho Okada
Also filed as: OKADA HIDEHO
17 granted patents·20 pending applications·170 citations·filing 2003–2024
93Inventor score
Files withUNIV CALIFORNIA14UNIV PITTSBURGH5OKADA HIDEHO3UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION3INTREXON CORP2
Top patents by PatentIndex Score
37 records- 0196US9394368B2Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptorBROGDON JENNIFER·Filed 2014·Granted Jul 19, 2016·112 cites·38 claims
- 0291US10441644B2H3.3 CTL peptides and uses thereofUNIV CALIFORNIA·Filed 2017·Granted Oct 15, 2019·4 cites·4 claims
- 0391US7612162B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV PITTSBURGH·Filed 2005·Granted Nov 3, 2009·20 cites·10 claims
- 0489US10308717B2Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptorNOVARTIS AG·Filed 2016·Granted Jun 4, 2019·4 cites·9 claims
- 0588US11865167B2Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptorNOVARTIS AG·Filed 2019·Granted Jan 9, 2024·2 cites·39 claims
- 0688US10849965B2H3.3 CTL peptides and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Dec 1, 2020·2 cites·18 claims
- 0788US8486911B2Th1-associated microRNAs and their use for tumor immunotherapyOKADA HIDEHO·Filed 2012·Granted Jul 16, 2013·12 cites·12 claims
- 0884US10434155B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Oct 8, 2019·3 cites·12 claims
- 0983US8859488B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseOKADA HIDEHO·Filed 2009·Granted Oct 14, 2014·5 cites·14 claims
- 1083US2024252608A1Peptide analogs capable of enhancing stimulation of a glioma-specific ctl responseUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2023·Application pending·0 cites
- 1178US12090170B2Methods of treating glioblastomasUNIV CALIFORNIA·Filed 2019·Granted Sep 17, 2024·1 cites·13 claims
- 1278US11723963B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Aug 15, 2023·0 cites·8 claims
- 1377US10874730B2Methods for treating brain cancer using il-13r alpha 2 peptide-based compositionsUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Granted Dec 29, 2020·1 cites·14 claims
- 1477US9675642B2Engineered dendritic cells and uses for the treatment of cancerINTREXON CORP·Filed 2013·Granted Jun 13, 2017·3 cites·7 claims
- 1574US11185577B2H3.3 CTL peptides and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Nov 30, 2021·0 cites·24 claims
- 1674US2025090636A1H3.3 ctl peptides and uses thereofUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1772US11925679B2H3.3 CTL peptides and uses thereofUNIV CALIFORNIA·Filed 2020·Granted Mar 12, 2024·0 cites·4 claims
- 1872US10617667B2Method for treating brain tumorsONO PHARMACEUTICAL CO·Filed 2018·Granted Apr 14, 2020·1 cites·15 claims
- 1972US2025034229A1Methods of treating egfrviii expressing glioblastomasUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 2071US2021338790A1Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccinesUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2020·Application pending·0 cites
- 2171US2024325449A1Methods of treating glioblastomasUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 2268US2013295046A1Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccinesUNIV PITTSBURGH·Filed 2013·Application pending·0 cites
- 2367US2015258185A1Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccinesUNIV PITTSBURGH·Filed 2014·Application pending·0 cites
- 2464US2022118069A1H3.3 ctl peptides and uses thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2561US2009123441A1Engineered Dendritic Cells and Uses for the Treatment of CancerUNIV PITTSBURGH OF COMMONWEALT·Filed 2008·Application pending·0 cites
- 2659US12144826B2Methods of treating EGFRvIII expressing glioblastomasUNIV CALIFORNIA·Filed 2019·Granted Nov 19, 2024·0 cites·8 claims
- 2759US2003223971A1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsFiled 2003·Application pending·0 cites
- 2857US2012052080A1Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccinesOKADA HIDEHO·Filed 2011·Application pending·0 cites
- 2956US2017312315A1Engineered Dendritic Cells and Uses for the Treatment of CancerINTREXON CORP·Filed 2017·Application pending·0 cites
- 3055US2013344039A1Th1-associated micrornas and their use for tumor immunotherapyUNIV PITTSBURGH·Filed 2013·Application pending·0 cites
- 3152US2010322909A1Th1-associated micrornas and their use for tumor immunotherapyUNIV PITTSBURGH·Filed 2010·Application pending·0 cites
- 3252US2021087252A1Mutant IDH1 Specific T Cell ReceptorBERKELEY LIGHTS INC·Filed 2020·Application pending·0 cites
- 3351US2012114620A1Engineered Dendritic Cells and Uses for the Treatment of CancerBRAUGHLER J MARK·Filed 2011·Application pending·0 cites
- 3449US2021023136A1Trans-antigen targeting in heterogeneous cancers and methods of use thereofUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 3548US2023055337A1Use of brain-specific antigens to home, block and deliver cell-based treatments to the brainUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3647US2022378832A1Use of mog for priming a treatment for glioblastomaUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3747US2022273714A1T-cell receptors and methods of use thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hideho Okada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →